Doctor Marzia Rigolli

Doctor Marzia Rigolli

Global Drug Development, San Diego (United States of America)

Member of:

Dr. Rigolli is a Cardiologist, Physician-Scientist (MD, DPhil), Director, Senior Clinical Trial Physician, Cardiovascular Global Drug Development. CV Imaging, Cardiomyopathies, Heart Failure and Valvular Heart Disease. She currently works at Bristol Myers Squibb. Dr Rigolli trained in Cardiovascular Medicine and Imaging at the University of Oxford, UK and at the University of Verona, Italy. Her doctoral studies were awarded a DPhil (PhD) from the University of Oxford before moving to the US to work on hypertrophic and rare cardiomyopathies at the University of California, San Diego. Her academic research examined the role of imaging in assessing clinical outcomes and treatment targets. Dr. Rigolli is currently developing drugs in cardiomyopathies (HCM) and Heart Failure. She is passionate about clinical trials, publishes in high-impact journals, and has won multiple young investigator awards.

Presentations

Cardiomyopathy phenotyping and risk-stratification in danon disease

Event: ESC Congress 2020

Topic: Myocardial Disease

Session: Latest Advances in Cardiac Magnetic Resonance

Access

Right ventricular dysfunction is associated with late mortality in severe aortic stenosis: results from a multi-centre outcome study in patients undergoing aortic valve replacement

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Imaging parameters in valvular heart disease

Access

Right ventricular dysfunction detected by cardiovascular magnetic resonance is associated with late mortality in severe aortic stenosis

Event: EuroCMR 2019

Topic: Valvular Heart Disease

Session: Rapid Fire Abstract 6: 4D flow and valvular heart disease: can CMR add value?

Access

COPD in symptomatic aortic stenosis: the importance of correct assessment for defining prognosis

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Prognosis in aortic stenosis

Access

Accuracy and inter-changeability in left ventricular quantification by multi-modality imaging: a systematic review and meta-analysis.

Event: ESC Congress 2016

Topic: Multimodality / hybrid imaging, other imaging

Session: Multi-modality imaging

Access

Doctor Marzia Rigolli

Biography

Contributor content

Cardiomyopathy phenotyping and risk-stratification in danon disease

Right ventricular dysfunction is associated with late mortality in severe aortic stenosis: results from a multi-centre outcome study in patients undergoing aortic valve replacement

Right ventricular dysfunction detected by cardiovascular magnetic resonance is associated with late mortality in severe aortic stenosis

COPD in symptomatic aortic stenosis: the importance of correct assessment for defining prognosis

Accuracy and inter-changeability in left ventricular quantification by multi-modality imaging: a systematic review and meta-analysis.

ESC 365 is supported by